肾透明细胞癌内科治疗进展与药物不良反应
Chinese Journal of Medicine(2006)
Abstract
肾透明细胞癌(renal cell carcinoma,RCC)与前列腺癌和膀胱癌并称泌尿系统三大恶性肿瘤,占所有男性恶性肿瘤的3%.我国肾肿瘤的粗死亡率为0.32/10万人,较欧美国家发病率低,肾透明细胞癌占全部肾肿瘤的85%,30%肾癌患者在明确诊断时,已经发生了远处转移.近年来肾癌发病率有上升趋势[1].本文就RCC内科治疗进展综述如下.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined